Patents Don’t Monetize Themselves: Turning Portfolios from Cost Centers into Revenue Assets

Imagine a company spends millions of dollars constructing a new office building in a prime downtown location. The company pays for maintenance, utilities, insurance, landscaping, repairs, security, and taxes. The building is well designed, professionally managed, and expensive to maintain. But it sits empty. No tenants. No leases. No revenue.

That would strike most executives as irrational. Yet many companies treat patent portfolios in exactly the same way. They spend millions building and maintaining patent portfolios around the world. They pay prosecution costs, maintenance fees, annuities, outside counsel fees, internal management costs, docketing costs, and renewal costs. They proudly report patent counts to the board, tout innovation metrics in annual reports, and point to their portfolio as proof of technical leadership. But when asked what revenue the portfolio generates, the silence is deafening.

Obviously, there is a better way to handle a patent portfolio, but it requires both discipline and desire. Patent monetization is not magic. It is not simply sending demand letters. It is not putting a patent number in front of a large company and hoping a check miraculously appears. Successful monetization requires a business case built on strong patents, credible evidence, realistic infringement theories, documented damages, and a willingness to enforce rights if—or more likely when—business negotiations fail.

The uncomfortable truth is that most patents in most portfolios will never drive meaningful licensing revenue. That does not mean the portfolio is worthless. It means value must be found, proven, and packaged. Monetization is not about believing a portfolio has value. It is about doing the work necessary to prove value to someone else.

Monetization Starts With Valuation, Not a Number

The value of a patent or portfolio is, in a very basic sense, tied to the likelihood that it can be successfully monetized. That means every serious monetization campaign must begin with a competent and defensible valuation exercise. That valuation may focus on a handful of patents selected for enforcement, a larger package of assets around a technology area, or an entire worldwide portfolio that could support a broader licensing initiative.

But valuation in the patent world is inherently difficult. Unlike real estate, publicly traded securities, or many physical assets, patent transactions and licensing agreements are often private, and transactions are limited in number, which makes finding comparables exceptionally difficult. And even when similar transactions do exist and can be found, real terms are rarely really comparable in any clean, apples-to-apples way. Even when royalty rates become known, those rates may be embedded in broader business arrangements involving cross-licenses, covenants, releases, geographic limitations, field-of-use restrictions, portfolio grants, litigation settlements, supply agreements, or other commercial terms.

That opacity makes it harder to identify market norms and harder to establish what a fair and reasonable licensing range should be. It also means that looking for one specific number as “the” fair market value of a patent is usually a fool’s errand. The number depends on the context: who owns the asset, who needs the technology, what products are implicated, how much revenue is at stake, how strong are the claims, whether the patent has survived any previous scrutiny, whether damages can be proven, and whether the patent owner can actually enforce the rights and see the fight all the way to the end.

In some contexts, particularly standard essential patents (SEPs), courts and licensing professionals have long used methodologies such as comparable licenses and top-down approaches. Comparable licenses look to actual market transactions. A top-down approach starts with the value of a standard or technology ecosystem and then allocates value to a particular set of patents. Both approaches can be useful, and both underscore a larger point: patent valuation must be tethered to market reality, not wishful thinking. For ordinary portfolio monetization outside the SEP context, the same business logic applies.

The First Screen: Validity, Use, and Proof

Before a patent owner spends money on a monetization campaign, three questions must be answered. First, are the patent claims likely valid over the prior art? Second, is the claimed technology actually being used in products or services in the marketplace, or likely to be used in the near future? Third, can the patent owner clearly demonstrate that use and connect it to a financial outcome?

Over most of the past 15 years validity became a threshold monetization issue because any serious licensing campaign would trigger an inter partes review (IPR) challenge at the Patent Trial and Appeal Board (PTAB). Since the start of the second Trump Administration, the PTAB has become substantially less important, with only 15 IPRs filed in April 2026 (see slide 5), down from 123 IPRs filed in April 2025. But even with the dramatic decrease in IPR filings, those challenges that have been instituted continue to show high invalidation rates, so the PTAB does continue to be a challenge for monetization if the IPR is instituted. Thus, it is still the case that any serious monetization campaign must anticipate an invalidity challenge, whether at the PTAB, in district court or at the Central Reexamination Unit, which is becoming a much more important forum for challengers.

Use of the innovation covered by the patent portfolio is also obviously equally critical. A patent portfolio that covers no meaningful commercial activity may be technically interesting, but it will not move a licensing negotiation, and it won’t produce revenue. The strongest monetization candidates are patents that read on products or services already in the market, particularly where those products generate meaningful revenue or support strategically important functionality. Of course, with SEPs it is a little more nuanced because a patent is legally considered “standard essential” even if it is not being used simply because patents become standard essential through disclosure to a standard setting organization. That said, it is still naïve to believe an SEP not being incorporated into a product or service will be as valuable as one that is.

Proof is the third leg of the stool, without which nothing is possible. It is not enough to suspect infringement. Monetization requires evidence of use. That evidence can come from product literature, technical documentation, data sheets, standards documents, user guides, repair manuals, reverse engineering, product testing, source-code review when available, teardown analysis, public statements, technical papers, marketing materials, or other sources that support the presence of each claim element. Finding evidence of use is becoming easier than it was once upon a time with the availability of artificial intelligence tools, but it is not easy. Finding evidence of use takes effort, and it requires being honest with yourself to truly appreciate just how persuasive the evidence is.

The Patent Owner Must Build a Monetization Thesis

Many companies’ approach to monetization is reactive. A product line is discontinued. A competitor enters the market. The CFO asks why the patent budget is so high. Suddenly, the idea pops into someone’s head: we have patents, can we use them to generate revenue. This is better than never asking the question in the first place, but the better model is systematic portfolio mining not looking for new revenue when other streams are weak.

A repeatable monetization process starts with more than patents and charts. It needs a thesis. This thesis must be clear enough for multiple audiences. Operating companies need to understand the business risk. Outside counsel needs to understand the litigation case. Litigation funders need to understand the investment profile. Potential buyers need to understand why the assets can be monetized. Internal executives need to understand why pursuing the campaign is worth the cost, distraction, and reputational risk that comes with asserting patents.

Unfortunately, many patent owners overestimate their leverage, believing ownership itself creates leverage and provides the thesis. It does not. Leverage comes from the target’s perceived risk of losing more by refusing to engage than by reaching a business resolution. That perception is driven by the quality of the evidence, the strength of the patents, the credibility of the damages case, and the patent owner’s ability to carry the matter through litigation if necessary.

In other words, a demand letter is not the monetization strategy. Asking for money without a thoroughly developed narrative supported by facts, figures and a healthy dose of realism and credibility is not a winning strategy. Skipping steps and rushing for the finish line won’t work and is why those with a systematic process in place tend to fair much better. Of course, everyone must start somewhere, and identifying the opportunity of a latent portfolio is a crucial first step. But there is no substitute for patience and preparation.

Litigation Finance Has Become Part of the Monetization Infrastructure

Patent enforcement is expensive, and that reality shapes everything associated with any monetization campaign. Large implementers understand the economics and weaponize delay. For a small patent owner, years of litigation can be financially ruinous. Even sizeable patent owners can easily find themselves at a strategic disadvantage. Companies like Apple and Alphabet report over $400 billion a year in revenue. Samsung brings in over $230 billion a year. And companies like Cisco and Intel are both over $50 billion a year in revenue.  Even a meritorious case built on strong, valid patents with exceptional evidence of use can collapse if the patent owner cannot fund a litigation that is likely to last a decade, or more.

Litigation finance can help rebalance that equation. It allows patent owners with good claims and a credible thesis to pursue enforcement without bearing the full cost alone. It also sends a market signal: someone with capital who has done diligence believes the case is worth funding.

That matters because despite stories to the contrary, sophisticated litigation funders do not invest casually. A credible funder conducts its own diligence, often after the patent owner, technical consultants, and contingency counsel have already reviewed the assets and liability themselves. In large cases, multiple independent financial professionals will evaluate the portfolio before capital is committed. That level of diligence is not a bug in the system. It is a quality filter.

There are, of course, bad actors in every market, and patent monetization is no exception. Some patent owners have asserted weak patents to extract nuisance settlements. Some implementers refuse to take any license under any circumstances, no matter how strong the patents and evidence of use. There is no serious doubt that both forms of gamesmanship distort the market. But serious litigation finance can and do help restore balance by allowing undercapitalized innovators to stand up to companies that otherwise could simply wait them out.

Building With Monetization in Mind

The best monetization strategy begins before monetization is ever contemplated. It begins during invention harvesting, drafting, prosecution, continuation practice, and portfolio management.

Claims should be drafted with detectability in mind. If infringement cannot be detected without impossible discovery, licensing leverage and monetization potential will be limited. Specifications should support commercially relevant claims with various claim scope. Continuations should remain pending wherever commercially justified so claims can evolve as markets develop and evidence emerges. Portfolios should be reviewed periodically against competitor products and market adoption, with appropriate investments made to bulk up a portfolio where competitors and the market show interest.

In this regard, it is essential for feedback from licensing and enforcement to flow back into prosecution. If claim terms repeatedly create proof problems, prosecutors need to be told. If certain types of claims survive diligence better than others, that must inform drafting. If market evidence shows competitors adopting a particular architecture, continuation strategy should account for that. If validity challenges expose recurring weaknesses, future filings need to be adjusted. This is how patent portfolios become business assets rather than a static inventory of the possible. Teams that work together build more monetizable portfolios.

Unprepared Patents Rarely Produce

Patent monetization is not easy, and pretending otherwise helps no one. The market is demanding. Implementers are sophisticated. PTAB and patent eligibility risk remain real. Litigation is expensive while licensing markets remain opaque. And against this backdrop we know that many patents—easily 90% of patents or more—will never generate revenue.

This does not mean monetization is a lost cause. But it does mean monetization efforts must be professional and systematic because patents and portfolios do not monetize themselves. And the reality is unprepared patents are rarely monetizable.

The path to revenue begins with a simple question every patent owner should be asking: if we had to prove the value of this portfolio to a sophisticated third party tomorrow, could we do it? If the answer is no, your work needs to start now so you can lay the foundation for a different future where your patent portfolio generates positive revenue instead of just being a cost center.

Catch in-depth analyses of this and other topics at IPWatchdog’s 2026 Patent Masters Program, being held live from Monday-Wednesday of this week.